07:00 , Sep 19, 2016 |  BC Week In Review  |  Financial News

Intarcia completes venture financing

Intarcia Therapeutics Inc. , Boston, Mass.   Business: Endocrine/Metabolic   Date completed: 2016-09-15   Type: Venture financing   Raised: $215 million   Investors: Baillie Gifford; Pritzker Family; Lucion Venture Capital; Baupost Group LLC; Fidelity; Foresite...
07:00 , Mar 21, 2016 |  BC Week In Review  |  Financial News

Orexigen completes private placement of senior convertible notes

Orexigen Therapeutics Inc. (NASDAQ:OREX), La Jolla, Calif.   Business: Endocrine/Metabolic   Date completed: 2016-03-15   Type: Private placement of senior convertible notes   Raised: $165 million   Shares outstanding prior: 145.6 million   Investors: Baupost...
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

Keryx completes private placement of senior convertible notes

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), New York, N.Y.   Business: Endocrine/Metabolic, Renal   Date completed: 2015-10-15   Type: Private placement of senior convertible notes   Raised: $125 million   Shares outstanding prior: 105.2 million   Investor:...
07:00 , Sep 14, 2015 |  BC Week In Review  |  Financial News

Orexigen completes private placement of common stock and warrants

Orexigen Therapeutics Inc. (NASDAQ:OREX), La Jolla, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-09-10   Type: Private placement of common stock and warrants   Raised: $60 million   Shares: 20 million   Price: $3  ...
07:00 , Jun 8, 2015 |  BC Week In Review  |  Financial News

Biotie completes private placement of convertible notes and warrants

Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland   Business: Neurology, Autoimmune, Inflammation   Date completed: 2015-05-29   Type: Private placement of convertible notes and warrants   Raised: EUR33.1 million ($36.1 million)   Shares outstanding prior: 456...
07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Biotie amends private placement of convertible notes and warrants

Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland   Business: Neurology, Autoimmune, Inflammation   Date announced: 2015-05-07   Type: Private placement of convertible notes and warrants   To be raised: Up to EUR33.1 million ($36.9 million)  ...
07:00 , Apr 27, 2015 |  BC Week In Review  |  Financial News

Biotie proposes private placement of convertible notes and warrants

Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland   Business: Neurology, Autoimmune, Inflammation   Date announced: 2015-04-23   Type: Private placement of convertible notes and warrants   To be raised: Up to EUR42.5 millon ($45.8 million)  ...
08:00 , Dec 21, 2009 |  BC Week In Review  |  Company News

Biogen Idec, Facet Biotech deal

Biogen Idec's tender offer of $17.50 per share expired at midnight on Dec. 16, with a majority of Facet's shares untendered. At the same time, Facet allowed its two largest shareholders, Biotechnology Value Fund and...
01:40 , Dec 17, 2009 |  BC Extra  |  Company News

Facet in deal with second shareholder

Facet Biotech Corp. (NASDAQ:FACT) agreed to allow its second-largest shareholder, The Baupost Group LLC, to increase its stake in the company from 14% to up to 20% without triggering Facet's rights agreement. The current ownership...